Skip to main content

Ternary Therapeutics

London, United Kingdom

Ternary Therapeutics is a biotechnology research center that specializes in bioinformatics and medicinal chemistry services.

$4.8M raised
Mar 2026
Seed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ternary Therapeutics

How much funding has Ternary Therapeutics raised?
Ternary Therapeutics has raised $4.8M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Who are Ternary Therapeutics's investors?
Ternary Therapeutics's investors include Daphni, UK Innovation & Science Seed Fund, Pace Ventures, i&i Biotech Fund.
Where is Ternary Therapeutics headquartered?
Ternary Therapeutics is headquartered in London, United Kingdom.
What does Ternary Therapeutics do?
Ternary Therapeutics is a biotechnology research center that specializes in bioinformatics and medicinal chemistry services.
What stage is Ternary Therapeutics at?
Ternary Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ternary Therapeutics — Funding & Investors." VCBacked, March 16, 2026, https://www.vcbacked.co/company/ternary-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2026). Ternary Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/ternary-therapeutics
Wikipedia (cite web)
{{cite web |title=Ternary Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ternary-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .